Fortis Healthcare Limited has informed the Exchange about approval of ESOP scheme 2026 by the shareholders.
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare Limited has received shareholder approval through postal ballot for its Employees Stock Option (ESOP) Scheme 2026. Three special resolutions were passed via e-voting, with the cutoff date of February 13, 2026, and voting concluded on March 18, 2026. Resolution 1 (ESOP Scheme 2026) was approved with 96.59% votes in favour. Resolution 2 (granting ESOPs to subsidiary company employees) passed with 96.70% in favour. Resolution 3 (granting ESOPs to associate company employees) saw 87.58% in favour and 12.42% dissent. All three resolutions cleared the required majority threshold. The scrutiny was conducted by Practicing Company Secretary Mukesh Kumar Agarwal, with e-voting facilitated by KFin Technologies.
This is a routine employee compensation-related approval and does not materially impact shareholders in the near term. It may lead to mild equity dilution over time once stock options are granted and exercised, but no immediate effect on stock price is expected.